The c-MET-JAK1/2-STAT3 signalling axis is regulated by ADAM17 and is a key mediator of resistance to MEK inhibition in KRAS mutant colorectal cancer

Sandra Van Schaeybroeck, Murugan Kalimutho, Philip Dunne, Wendy Moore, Puthen Jithesh, Catherine Fenning, Robbie Carson, Daniel Longley, Patrick Johnston

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Fingerprint

Dive into the research topics of 'The c-MET-JAK1/2-STAT3 signalling axis is regulated by ADAM17 and is a key mediator of resistance to MEK inhibition in KRAS mutant colorectal cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology